SIGMA has established a share sale
facility for holders of unmarketable
parcels in the company.
An unmarketable parcel of shares
with a market value of less than
$500 is any shareholding of 719
shares or less.
Sigma has around 1800
shareholders with an unmarketable
parcel of shares.
To assist these shareholders
Sigma is offering a facility to sell
shares without having to use a
broker or pay brokerage costs, with
the company vowing to pay all
costs of sale for shareholders who
make use of the service.
The move is designed to reduce
costs associated with maintaining
small shareholders (such as printing
and mailing costs of annual reports
etc).The above article was sent to subscribers in Pharmacy Daily's issue from 20 Sep 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Sep 12
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.